Biomarkers, Comorbidities, and Population Health in Major Depressive Disorder

Major depressive disorder (MDD) is a complex mental health condition shaped by biological, psychological, and social factors. Research on biomarkers and comorbidities provides valuable insight into the underlying mechanisms of MDD, including biological changes that may influence its development, severity, and response to treatment. Examining these factors at the population level can help identify patterns of risk, improve early detection, and support more personalized approaches to care. A deeper understanding of the relationships among biomarkers, co-occurring health conditions, and population health may contribute to more effective prevention and treatment strategies while reducing the overall burden of MDD. Biomarkers, Comorbidities, and Population Health in Major Depressive Disorder explores the biological markers associated with MDD and examines how co-occurring physical and mental health conditions may affect its onset, progression, severity, and treatment outcomes. Adopting a population health perspective, this book investigates risk patterns, supports earlier identification of vulnerable populations, and informs more effective prevention and intervention strategies. Covering topics such as environmental stressors, neurological diseases, and sleep disorders, this book serves as a valuable resource for medical and healthcare professionals, psychologists, biologists, researchers, and scientists.